Simon Fraser University researchers hope that a brain vital-sign test becomes as routine during a doctor’s check-up as taking a blood pressure or heart rate measurement.
SFU researchers, led by professor Ryan D’Arcy with partners from the Mayo Clinic, Sheba Medical Centre in Israel and local high-tech company HealthTech Connex Inc., are developing a more accessible means to monitor brain health.
In a recent article published in the journal Frontiers in Neuroscience, the team introduces the world’s first advancement in physiology-based brain vital signs. Their discovery makes it possible to translate complex brainwaves into objective, practical and deployable brain vital signs, using longstanding brainwave technologies that have existed for nearly a century.
HealthTech Connex Inc. is currently developing the NeuroCatchTM platform to enable the highest quality recordings of the brain’s vital signs.
“The brain vital-sign framework described in Frontiers in Neuroscience represents the first step towards an easy way to monitor brain health,” says D’Arcy. “Potential applications are in concussion, brain injury, stroke, dementia and other devastating brain diseases and disorders.”
Vital sign measures are often used in clinics, hospitals and other care centres to assess the performance of various body systems.
Scientists in D’Arcy’s NeuroTech Lab, based in Surrey Memorial Hospital, have now developed a simple way to measure brain health over time by using non-invasive electrodes to track the brain’s electrical activity for key brain functions—in other words, the brain’s vital signs.
Researchers found that it is possible to monitor brain performance during auditory sensation, and basic attention and cognitive processing.
“We know brainwaves provide an objective physiological measurement of brain functions,” says D’Arcy, SFU’s BC Leadership Chair in Medical Technologies. “We’ve been working for the last 20 years to solve the major gap in terms of utilizing this for a rapid and accessible vital sign for brain function.”
Traditionally, brain function has been assessed only after trauma or disease has occurred and has relied heavily on subjective, behaviour-based assessments.
“However, tracking our brain’s vital signs is critically important for establishing a baseline for a person’s objective brain activity,” he adds, noting that in the event of injury or disease, it then becomes possible to evaluate if brain function changes, and whether treatments are effective.
“We describe the world’s first physiology-driven brain vital-sign measure allowing us to quantify brain vitality over time,” says Sujoy Ghosh Hajra, a PhD student working with D’Arcy and the paper’s lead author.
In the paper, researchers describe how their framework translates complex brainwave science into clinically accessible information and demonstrates successful measurement of brain vital signs in both younger and older adults. Their method identified age-related brain function changes that were not evident using traditional measures.
The paper has had significant hits—more than 1,000 views globally—which Ghosh Hajra says is a testament to the urgent need to quantify brain vitality.
Learn more: Brainwaves could be the next health vital sign
The Latest on: Brain vital-sign test
via Google News
The Latest on: Brain vital-sign test
- Complex Regional Pain Syndrome: Comparing Adults and Adolescentson February 23, 2021 at 4:00 pm
In CRPS, the pain signals are an aberrant alteration of this vital sign. In this condition, the pain signal to the brain is exaggerated and inappropriate. A way to explain the process in concrete ...
- Decompressive Hemicraniectomy With Duraplasty: A Treatment for Large-Volume Ischemic Strokeon February 20, 2021 at 4:00 pm
Such patients require hourly vital sign checks, including ICP and CPP ... may be necessary to monitor associated edema and general brain progress and to determine final infarct size.
- Can Cognitive Assessment Become a Routine Part of Checkups?on February 18, 2021 at 4:00 pm
“In my view, cognitive status is a vital sign,” says inventor Charles ... problems are just what I like to call ‘brain clutter’ . . . Before Cognivue, we just had to say ‘time will tell.’” The test ...
- Machine Learning ‘Sniffs’ Out Long QT Otherwise Unseen on ECGon February 11, 2021 at 1:00 pm
“So, if there is a pregenetic test way of catching these individuals ... tool or a 6th grade or kindergarten screening tool or rooming the patient as a vital sign tool type thing.” ‘Much More ...
- On the Grind: The World of Do-It-Yourself Implantson February 10, 2021 at 4:00 pm
An online-based group called Grindhouse Wetwares is currently developing an implant codenamed Circadia, which, if successful, will read biomedical and vital sign data and transmit ... or even himself, ...
- Contactless analysis of heart rate variability during cold pressor test using radar interferometry and bidirectional LSTM networkson February 4, 2021 at 10:35 am
A total of 638 minutes of data is gathered from 25 test subjects and is analysed extensively. High F-scores of over 95% are achieved for heartbeat detection. HRV indices such as HF norm are ...
- CE Article: A Review of Street Drugs, Part 2on January 30, 2021 at 3:06 am
The heralding of pain as the fifth vital sign is often considered an inciting ... 7 It binds to opiate receptors in the brain, leading to the release of dopamine and subsequent sensations of ...
- KI-67, P53 and EGFR Immunohistochemistry of Canine Brain Tumourson August 17, 2020 at 2:19 pm
In veterinary medicine, information about Ki-67, p53 and EGFR expression in brain tumours is scarce ... Statistically, non-parametric Mann-Whitney test showed no difference between gliomas and ...
- Diagnostic Blood Tests in Minutes: Interview with Brianna Wronko, Founder and CEO of Group K Diagnosticson January 25, 2019 at 11:30 am
Wronko: This will not be an at-home test. It will be like any other vital sign monitor at a clinic. We’re aiming for a CLIA waiver, which would enable medical assistants to perform the test in ...
- USL261-401 Seizure Clusterson May 1, 2017 at 1:52 am
A maximum of approximately 350 subjects, aged 12 years or older, with a documented history of seizure clusters and on a stable antiepileptic drug (AED) regimen will be enrolled in the Test-Dose Phase ...
via Bing News